Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries--data from the European Heart Rhythm Association White Book
Open Access
- 31 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 13 (5) , 654-662
Abstract
Sudden cardiac death (SCD) is a major health concern in developed countries. Many studies have demonstrated the efficacy of implantable cardioverter defibrillator (ICD) therapy in the prevention of SCD and total mortality reduction. However, the high individual costs and the reimbursement policy may limit widespread ICD utilization. This study analyzed the temporal and the geographical trends of the ICD implantation rate. Data were gathered from two editions of the European Heart Rhythm Association (EHRA) White Books published in 2008 and 2009. The analysis revealed significant differences in the rates of ICD implantation per million capita between the countries, but the median implantations was constantly increasing. The number of ICD implantations correlated with gross domestic product (GDP), GDP per capita, expenditure on health, life expectancy, and the number of implanting centres. There are great number of differences in the ICD-implanting rates between EHRA member countries, consequent to the increase in the number of ICD implantations. The ICD implantation rates are related to national economic status and healthcare expenses.Keywords
This publication has 20 references indexed in Scilit:
- Tracing the European course of cardiac resynchronization therapy from 2006 to 2008EP Europace, 2010
- Core curriculum for the heart rhythm specialist†EP Europace, 2009
- The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe?EP Europace, 2009
- Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European populationEP Europace, 2009
- Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07EP Europace, 2008
- Trends in Hospitalization for the Implantation of Cardioverter-Defibrillators in the United States, 1990–2005The American Journal of Cardiology, 2008
- Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trialEP Europace, 2008
- Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart FailureCirculation, 2006
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1999